No intubation n :46 (56.8%) | Intubation n:35 (43.2%) | p | ||||
---|---|---|---|---|---|---|
Age | 75.93 ± 11.39 | 78.51 ± 12.49 | 0.336* | |||
Gender | Male | 18 | 39.13% | 17 | 48.57% | 0.395+ |
Female | 28 | 60.87% | 18 | 51.43% | ||
Present clinical situation | Asthma Attack | 2 | 4.35% | 0 | 0.00% | 0.503ǂ |
Decompensated cardiac failure | 19 | 41,30% | 7 | 20.00% | 0.073+ | |
Hypertensive pulmonary edema | 4 | 8.70% | 8 | 22.86% | 0.144+ | |
Interstitial lung disease | 0 | 0.00% | 1 | 2.86% | 0.890ǂ | |
COPD Attack | 15 | 32.61% | 13 | 37.14% | 0.849 | |
Malignant effusion | one | 2.17% | 0 | 0.00% | 0.890ǂ | |
Pneumonia | 5 | 10.87% | 6 | 17.14% | 0.625+ | |
Hypertension | 38 | 82.61% | 21 | 60.00% | 0.023+ | |
Diabetes Mellitus | 15 | 32.61% | 11 | 31.43% | 0.910+ | |
Congestive heart failure | 17 | 36.96% | 5 | 14.29% | 0.023+ | |
Coronary artery disease | 15 | 32.61% | 9 | 25.71% | 0.501+ | |
Chronic renal failure | 4 | 8.70% | 2 | 5.71% | 0.612+ | |
Chronic obstructive pulmonary disease + Asthma | 24 | 52.17% | 17 | 48.57% | 0.748+ | |
Cerebrovascular accident | 5 | 10.87% | 7 | 20.00% | 0.252+ | |
Chronic kidney disease | 2 | 4.35% | 3 | 8.57% | 0.434+ | |
Alzheimer’s | 3 | 6.52% | one | 2.86% | 0.451ǂ | |
Malignity | 3 | 6.52% | 2 | 5.71% | 0.881+ | |
Under The Mask Spo2 | 88.46 ± 5.55 | 78.4 ± 10.97 | 0.0001* | |||
Respiration Rate | 38.28 ± 4.55 | 38.63 ± 5.35 | 0.754* | |||
RASS Agitation Score | 2.17 ± 0.68 | 2.66 ± 0.73 | 0.003* | |||
A second administration of ketamine necessary? | No | 46 | 100.00% | one | 2.86% | 0.0001 ǂ |
Yes | 0 | 0.00% | 34 | 97.14% | ||
Adverse effect of ketamine | No | 39 | 84.78% | 33 | 94.29% | 0.178+ |
Yes | 7 | 15.22% | 2 | 5.71% |